Skip to content

DR. STEFAN ORIS

Active
Private limited companyfounded 1996active for 30 yearsLichtaartseweg(HRT) 237, 2200 Herentals, BelgiumKBO/BCE: BE 0458.600.162
Summary

DR. STEFAN ORIS has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €2.4m and a net result of €427,069. Equity is growing by about 2.6% per year across the filed financial years. Its solvency ranks better than 69% of 291 sector peers (NACE 86, financial year 2026). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
9th largest company by equity in Herentals, Health and social work sector1 site
Size
€2.7mtotal assets 2026
Staff
1 FTE
Equity
€2.4m
Profit
€427,069
Turnover not published (micro format)
Financial health
94 Excellent Checked score 2026
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2026 accounts 111 days early3 deeds in the Belgian Official Gazette
Why 94raises riskLiquidity: current ratio 6.56, cash €61,991, halvedlowers riskSector: Human health activities (NACE 86)Size: total assets €2.7mFigures for financial year 2026 (filed 12-10-2026)Show the evidence

Checked score

Score 2026
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 52% of its sector peers (NACE 86, small)
Financial strength · tick = 2025
Strong
Solvency 100=
equity 88.3% of total assets
Liquidity 52-5
short-term debt 11.7% · cash 2.3%
Profitability 77-9
return on assets 15.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,074 companies, NACE 86, small)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024highest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €220,000 on 30-day terms is acceptable
Liquidity ample (current ratio 6.56, compared with 5.89 in 2025, above the usual 1.5; short-term debt: 11.7% and cash: 2.3% of total assets), and 11.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 77% on solvency, 26% on liquidity, 36% on profitability and 70% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €2.7m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Liquidity: current ratio 6.56, cash €61,991, halved
NBB · annual accounts
lowers risk · Figures for financial year 2026 (filed 12-10-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2026 was due by 31-01-2027 and was filed on 12-10-2026, 111 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
111 days early
2025
45 days early
2024
2 days early
2023
22 days early
2022
28 days early
2021
on the day
2020
10 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 31 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 30-06-2027 and is due by 31-01-2028. Nothing is late today. The company usually files around 3 January (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today30-06-2027 year end31-01-2028 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2026 · micro…
  2. Highest result from 2019 to 2026net €427,069 ▲27.8%
  3. Annual accounts filedfinancial year 2025 · micro…

Key points

  • Positive: Among the best 5% on net resultsector median €76,526 · 291 companies €427,069 View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2026: €427,069 8 years View
  • Positive: Result rose in 2026from €334,063 to €427,069 ▲ 27.8% View

By topic

Financials

Financial year
2026
Total assets
€2.7m
Profit
€427,069
Solvency
88.3%
Total assets▲ 13.7%
Net result
20192026
Go to Financials

Timeline

Events
34
Since
1998
Next accounts
by 31-01-2028
  1. 30-06-2025Equity above €2m
  2. 29-01-2025Annual accounts filed
  3. 09-01-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
02-08-1996
Year ends
30-06
Peppol
Reachable for e-invoices
Go to Company details

Key facts about DR. STEFAN ORIS

What is the company number of DR. STEFAN ORIS?
0458.600.162. In Belgium the VAT number is the company number with BE in front: BE 0458.600.162.
Where is DR. STEFAN ORIS based?
The registered office is at Lichtaartseweg(HRT) 237, 2200 Herentals.Company details
What does DR. STEFAN ORIS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. STEFAN ORIS?
Private limited company (BV).
When was DR. STEFAN ORIS founded?
On 02-08-1996.
Is DR. STEFAN ORIS still active?
Yes, DR. STEFAN ORIS is an active enterprise in the KBO register.
How many employees does DR. STEFAN ORIS have?
On average 1 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
What is the turnover of DR. STEFAN ORIS?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is DR. STEFAN ORIS profitable?
In financial year 2026, DR. STEFAN ORIS made a profit of €427,069.
Where can I find the annual accounts of DR. STEFAN ORIS?
DR. STEFAN ORIS filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of DR. STEFAN ORIS due?
By 31-01-2028, for financial year 2027.Timeline

Companies related to DR. STEFAN ORIS

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.